
Johnson & Johnson Medtech Presents 3-Month Data From Omny-IRE Clinical Trial At 2025 Heart Rhythm Society Annual Meeting
(MENAFN- PR Newswire) Omny-IRE data demonstrated the investigational OMNYPULSETM Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety outcomes1 Additional data presented from …